guideline recommendations while the language barrier was perceivedasanobstacleforimplementation.Theteammade useofexistingguidelinesofAUA,EAU,NICE,andEBRO inTheNetherlands,nexttotheCochranelibraryandPubMed forsystematicreviews.
Worldwide there is a need for guidance of clinicians in their daily work when faced with dilemmas and the need to takeappropriatedecisions.Physiciansinuniversityandcommunity-based hospitals have become dependent on continuousmedicaleducationandclearandconciseguidelineswhich helpguidethemtokeepupwiththeevergrowingnumberof clinicalreports.Theclinicallandscapeisconstantlychanging sincepatientpopulationsattimeofdiagnosischangedueto changes in lifestyle, new imaging techniques for diagnosing evolve, whereas novel treatment options including operational procedures and therapeutic compounds appear rather fastatthehorizon.Practiceguidelinesclearlyofferpractical solutions to clinicians and need to be frequently updated to be useful to clinicians. According to Shekelle et al. [4] , as a generalrule,guidelinesshouldbereassessedforvalidityevery 3years.Aquickupdateprocessofa'livingguideline'isforeseenbythecurrentsteeringcommittee.
Guidelinesaremorelikelytobeadoptedaslongasthereis astrongprofessionalsupportandiftheimplementationdoes not result in increased healthcare costs. The German guidelines involved a wide range of experts, although this apparentlydidnotalwaysmakethetaskeasier.Thepublicconsultation before final editing of the guidelines is a remarkable andpotentiallyvaluableapproachtokeepclosecontactwith thebasis.Thisapproachmayprecludepotentialunwillingness ofthepatientstoundergoacertaintreatmentandthusresult inenhancedadherencetotheguidelinesdeveloped.Itwould beofinteresttoobtainmoredetailedinformationwhy(only) 5 out of 23 comments received from the public consultation periodwereadopted.
In this months' issue of OnkOlOgie, Christoph Rölling and co-workersdescribetherigorousandtime-consumingdevelopmentalprocesswhichresultedintheinterdisciplinaryevidence based German S3 guidelines on diagnosis and treatmentofprostatecancer [1] .Theprocessencompassedahuge amountofworkandwasinitiatedbytheGermanSocietyof Urology (DGU). The efforts took place over a period of severalyears,startedin2005andwerefinalizedandpresented inSeptember2009.Röllingetal.providedetailedinformation concerningthecompositionofthegroupofdifferentprofessionalstakeholders,disciplines,involvedinthedevelopment process, including members of the steering group, the research team involved in selecting, reviewing and rating the evidence, and individuals involved in formulating the final recommendations.Expertsfrom10differentmedicalsocieties or organizations, the Center for Quality in Medicine (Ärtz-lichesZentrumfurQualitätindeMedizin,ÄZQ)andapatient organization were involved in the development of the guidelines. This process required several meetings over the yearsandadditionalre-evaluationsteps.Withthisdetailedreporttheauthorsadequatelydealwiththeincreasingconcern about the quality, reliability and independence of practice guidelinessinceinformationonthemethodologicalqualityof theguidelinesdevelopedbyspecialtysocietieshasnotalways beenavailable [2] .
Inthepast,guidelinedevelopmenthasbeenlargelybased onexpertopinion,andtheviewsandopinionsofotherstakeholders [3] . In Germany, before 2005, apparently only one high quality, evidence based medicine (EBM) guideline existed (referred to as S3 according to the definition of the ScientificMedicalSocietiesinGermany)anduntilthenGermanguidelinesinUrologywereexclusivelybasedonexpert consensusof'evidence'(levelS1/S2).Thisaskedforevidence based guidelines since various differences in the health care systemlimittheapplicabilityofinternationalevidencebased Osanto/vanPoppel Interestingly,ofthe12,899hitsscreened,only420publica-tions were included as source of evidence underscoring that thevastmajorityofliteratureisnotusefulforevidencebased medicine regimens. However, in our opinion, small studies and valid clinical observations may still be highly relevant under certain circumstances notwithstanding the compelling evidence in favor of adhering to level-one evidence recommendations. Evidence based medicine applies to 'groups of people'andoneshouldnotdiscountthe'importanceofclinical expertise'.
Some questions remain after reading the article. Were initialrecommendationssubstantiallychangedafterthevalidationbythetotalgroupbytelephoneconferencesanddaily meetingsandwhatcriteriahavebeenapplied(e.g.costs,logistics,ethics).Itisnotclearwhethercostsofdifferentmethods of diagnosis and treatment have been taken into account in theultimaterecommendations.Wereadaptationsmadeinthe initialrecommendationsbasedontheclinicaldirectnessand applicabilityintheGermansociety,knowingthatextrapolating data used in a clinical situation which differs from the originalclinicalstudysituationmayleadtomajordifferences inoutcomeforthepatient.Thus,informationaboutwhether and to what extent the recommendations were modified by takingintoaccountnotonlythequalityoftheexistingdatain theliterature,butalsosuchothervariableswouldhavegiven moreinsightinthequalityoftheultimaterecommendations. The future now lies in investment in the dynamics of guidelinesrequiredinaneverchanginglandscapeandtotestwhat percentage of recommendations are indeed implemented or divertedfromindailypractice. Thus, the next task for the DGU after the finalization of theguidelinesonprostatecanceristheassessmentoftheimpact on daily practice and to monitor adherence to their guidelines produced by subspecialty medical societies and generalmedicalsocietiesinordertomeasurethetruevalue on health care. In principal, guidelines and evidence-based medicine aims for the ideal that health care professionals make conscientious use of current best evidence in their everydaypractice,butadherencetoguidelinesisknowntobe rathervariableashasbeenshownfortheguidanceissuedby the National Institute for Clinical Excellence (NICE) in the UK [5] . Alongside with the continuous evolution of health care technologies, evidence based medicine and practice guidelines, the limitations of EBM guidelines have also becomeapparentandcriticsofEBMarguethatguidelinesare most appealing to health economists, policymakers and managers,formeasuringperformanceanddecidingonfinancialresources.
The question remains why each country should prepare their own national guidelines instead of sharing data which haveemergedandbeenalreadypublishedelsewhere.Forthe currentGermanguidelines,guidelinesandrecommendations in other countries and from other organizations have been used.Clearly,practicalrecommendationsmaybeinfluenced by local circumstances, specialist density, doctors' training, availabilityofimagingandradiotherapyequipment,national insurance and coverage policies and other differences between health care systems in different countries. However, theadoptionofcommonstandardsshouldimprovetheconsistency and quality in the reporting of guideline development worldwide and provide a framework to encourage internationalcomparisonofclinicalpracticeguidelines.
Joining already established international collaboration of researchersandpolicymakerswhoseektoimprovethequality and effectiveness of clinical practice guidelines by establishingasharedframeworkfortheirdevelopment,reporting andassessment,maybethenextstep.
